EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain

Álvaro Serrano-Ortiz, Juan Luis Romero-Cabrera, Jaime Monserrat Villatoro, Jaime Cordero-Ramos, Rafael Ruiz-Montero, Álvaro Ritoré, Joaquín Dopazo, Jorge Del Diego Salas, Valle García Sánchez, Inmaculada Salcedo-Leal, Miguel Ángel Armengol de la Hoz, Isaac Túnez und 1 weitere

Journal of Epidemiology and Global Health · 2024

DOI: 10.1007/s44197-024-00298-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Epidemiology and Global Health, 2024. Verfasst von Álvaro Serrano-Ortiz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Preventive Medicine and Public Health Unit, Reina Sofía University Hospital, Córdoba, Spain. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Machine Learning, SARS-CoV-2. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 vaccination has become a pivotal global strategy in managing the pandemic. Despite COVID-19 no longer being classified as a Public Health Emergency of International Concern, the virus continues affecting people worldwide. This study aimed to evaluate risk factors and vaccine effectiveness on COVID-19-related hospital admissions, intensive care unit (ICU) admission and mortality within the Andalusian population throughout the pandemic.

Methods

From March 2020 to April 2022, 671,229 individuals, out of 9,283,485 with electronic health records in Andalusia, experienced SARS-CoV-2 infection and were included in the analysis. Data on demographics, medical history, vaccine administration, and hospitalization records were collected. Associations between medical history, COVID-19 vaccines, and COVID-19 outcomes were assessed.

Results

Our study identified 48,196 hospital admissions, 5,057 ICU admissions, and 11,289 deaths linked to COVID-19. Age, male sex, and chronic diseases were identified as risk factors, while the COVID-19 vaccine demonstrated protective effects, although with reduced effectiveness during the omicron variant period. However, the risk for these outcomes increased over time after receiving the last vaccine dose, particularly after six months, especially among those aged 60 or older.

Conclusion

The global health challenge of COVID-19 persists, marked by emerging variants with higher virulence and severity, particularly among the unvaccinated and those beyond six months post-vaccination, especially those aged 60 and above. These findings highlight the need for robust surveillance systems targeting new variants and administering booster doses, particularly for individuals aged 60 or older with underlying health conditions, to mitigate the global burden of COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesMachine LearningSARS-CoV-2HospitalizationHumansSpainMaleFemaleMiddle AgedRisk FactorsAgedAdultVaccine EfficacyIntensive Care UnitsAged, 80 and overYoung AdultAdolescent

Stichwörter der Autor:innen

COVID-19Cohort studyEpidemiologyHealth policyVaccines

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Preventive Medicine and Public Health Unit, Reina Sofía University Hospital, Córdoba, Spain.
  • Preventive Medicine and Public Health Research Group, Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
  • Preventive Medicine and Public Health Unit, Healthcare Management Area: South of Córdoba, Cabra, Córdoba, Spain.
  • Lipids and Atherosclerosis Unit, Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain.
  • CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Health District of Córdoba and Guadalquivir, Córdoba, Spain.

Zitieren

APA

Serrano-Ortiz, Á., Romero-Cabrera, J. L., Monserrat Villatoro, J., Cordero-Ramos, J., Ruiz-Montero, R., Ritoré, Á., Dopazo, J., Del Diego Salas, J., García Sánchez, V., Salcedo-Leal, I., Armengol de la Hoz, M. Á., Túnez, I., & Guzmán, M. Á. (2024). Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain. Journal of Epidemiology and Global Health. https://doi.org/10.1007/s44197-024-00298-2

Vancouver

Serrano-Ortiz Á, Romero-Cabrera JL, Monserrat Villatoro J, Cordero-Ramos J, Ruiz-Montero R, Ritoré Á, et al. Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain. Journal of Epidemiology and Global Health. 2024. doi:10.1007/s44197-024-00298-2

BibTeX
@article{SerranoOrtiz2024,
  author = {Serrano-Ortiz, Álvaro and Romero-Cabrera, Juan Luis and Monserrat Villatoro, Jaime and Cordero-Ramos, Jaime and Ruiz-Montero, Rafael and Ritoré, Álvaro and Dopazo, Joaquín and Del Diego Salas, Jorge and García Sánchez, Valle and Salcedo-Leal, Inmaculada and Armengol de la Hoz, Miguel Ángel and Túnez, Isaac and Guzmán, Miguel Ángel},
  title = {Assessing COVID-19 Vaccine Effectiveness and Risk Factors for Severe Outcomes through Machine Learning Techniques: A Real-World Data Study in Andalusia, Spain},
  journal = {Journal of Epidemiology and Global Health},
  year = {2024},
  doi = {10.1007/s44197-024-00298-2}
}
Kostenlos starten →